OR WAIT null SECS
June 02, 2022
Lions and tigers and monkeypox, oh my!
May 02, 2022
A long-running criminal case involving the theft of confidential data from a pharma giant is still unravelling, as more convictions are made.
Fresh insight is instrumental in the discussion of novel analytics.
April 02, 2022
The AMR Action Fund has made its first investments, marking an important step forward for the partnership to achieve its goal of bringing new treatments to the market for priority pathogens.
3D cell cultures could provide key avenues to unlocking critical information.
March 02, 2022
As Russia’s invasion of Ukraine continues, industry leaders speak out in condemnation of the actions taking place and pledge to provide aid to those in need.
Borrowing is good, but invention is best.
February 02, 2022
As company revenues are gaining a boost from COVID-19, the issue of pricing is being debated once more.
The process of reshaping inevitably leads to fresh insights.
January 02, 2022
Overall, 2021 proved to be another good year for drug approvals in Europe, albeit with a slight disappointment for Alzheimer’s patients, but what should industry be watching out for in 2022?